| |
| |
Within the sphere of oncology
clinical development, too often
products are delayed getting to the market
either by the lack of oncology clinical
development expertise or the lack of
patients for the drug’s clinical trials. The two
founders of Veeda Oncology, Mr. Binoy Gardi and
Mr. Apurva Shah, had a vision of creating a
truly global oncology CRO that would provide
clients with world-class oncology expertise
along with rapid and cost-effective access to
oncology/hematology patients around the globe
With the creation of Veeda Oncology, our
focus has been to address the critical issues
that often face sponsors in oncology drug
development - access to oncology patients
globally and the ability to launch clinical
trials rapidly. With locations in India and
Western and Eastern Europe, as well as in the
United States, Veeda Oncology provides access to
numerous clinical sites throughout the world
with greater access to patients with cancer.
Veeda
Oncology has been involved in over 50
oncology clinical trials ranging from
Phase I thru Phase IV. These programs include
both solid tumor trials as well as hematology
trials. (Please see the tab marked “Experience”
for further information.)
During the coming year, our corporate
objective is to further expand our global
capabilities so that we can continue to meet or
exceed the accrual needs of our oncology
clients. |
| |
